Introduction
B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in adults in the western world. 1 Unlike other leukemias, there is only a small proportion of proliferating neoplastic cells, which are localized in the so-called 'pseudofollicles' in the lymph nodes and are scattered in the bone marrow (BM) of the patients. [2] [3] [4] The majority of leukemic cells in B-CLL are nonproliferating cells arrested in the G 0 /G 1 phase, which accumulate gradually in lymphoid organs, BM and peripheral blood (PB), due to a selective survival advantage enjoyed by these cells. 5 Both, intrinsic defects in the cells regulation of programmed cell death (apoptosis) and an altered, survival-stimulating microenvironment are discussed as major pathogenic factors of B-CLL. [6] [7] [8] [9] [10] [11] The importance of external survival factors is exemplified by the fact that B-CLL cells rapidly undergo spontaneous apoptosis under culture conditions that support the growth of human B cell lines. 12 On the other hand, B-CLL cells can be rescued from apoptosis ex vivo, when cocultured with BM-derived stromal cells. 13 B-CLL cell survival in these cocultures is associated with an active phosphatidylinositol-3 kinase/Akt signaling pathway and with increased expression of anti-apoptotic proteins like Bcl-2. [14] [15] [16] Probably owing to the quiescent nature of circulating B-CLL cells, B-CLL tumor cell lines have never been obtained unless infected in vitro or in vivo by Epstein-Barr virus. 17, 18 On the other hand, primary B-CLL cells can be obtained easily from the PB of patients and represent the ideal system to study the molecular mechanisms of B-CLL pathogenesis. Major drawbacks for experiments with these cells have been the rapid spontaneous apoptosis of B-CLL cells ex vivo and their resistance to transient gene delivery with most currently available gene transfer systems.
In the present study, we established a coculture system using the human BM-derived stromal cell line HS-5, which enables long-term survival of primary human B cells and B-CLL cells ex vivo. In addition, we developed a strategy to efficiently transfect primary B cells and B-CLL cells, and document that introduction of circular plasmid DNA, but not mRNA or siRNA, into these cells causes apoptosis.
Materials and methods

Primary cells and cell lines
PB samples were obtained from 17 B-CLL patients (see Supplementary Information A) and five healthy donors after informed consent. All 17 B-CLL cases matched the standard diagnostic criteria for B-CLL. The human BM-derived stromal cell line HS-5 was purchased from American Type Culture Collection (Manassas, VA, USA).
Cell isolation and culture
PB mononuclear cells were isolated by Ficoll density gradient. Thereafter, B-CLL preparations consisted of 480% CD19 þ cells as measured by flow cytometry and were used without further enrichment. Fractions of B-CLL cells were cryopreserved in cell culture medium containing 10% fetal calf serum (FCS) and 10% dimethylsulfoxide. After thawing, B-CLL cells were cocultured for 1-2 days with HS-5 stromal cells before experiments were performed. We reassessed the percentage and viability of B-CLL cells thereafter, which were 490 and 470%, respectively. CD19 þ cells from healthy donors were enriched by magnetic bead-activated cell sorting (MACS) using CD19-MicroBeads and following the instructions of the manufacturer (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the CD19 þ cell preparations was 495% as measured by flow cytometry. All cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FCS, 4 mM L-glutamine, 4.5 g/l glucose, 100 U/ml penicillin and 100 mg/ml streptomycin, and were cultured at 371C in a 10% CO 2 humified incubator. For cocultures, HS-5 cells were seeded at a density of 3 Â 10 5 cells/ml in 24-well plates 3 h before the addition of equal numbers of primary B cells or B-CLL cells. After the indicated incubation times, B cells and B-CLL cells were separated from the adherent HS-5 cells by shaking and carefully rinsing the wells of the plate. Purity of the cell fractions after coculture was quantified by flow cytometry. For experiments with conditioned medium of HS-5 cultures, the medium was removed from more than 70% confluent stromal cell layers, freed from cells by centrifugation for 10 min at 1000 g and added immediately to B-CLL cells in culture. In survival studies over several days, the conditioned medium was replaced daily.
DNA and mRNA preparations pmax green fluorescent protein (GFP) was obtained as part of the Human B cell Nucleofector Kit from Amaxa (Cologne, Germany). pcDNA-GFP was produced by excising maxGFP out of pmaxGFP and cloning it into pcDNA6/V5-His cloning vector (Invitrogen, Karlsruhe, Germany) using KpnI and XhoI restriction sites. CD79b was PCR amplified from B-CLL cells using the following primers: 5 0 -GAGAGAGAATTCGTGAC CATGGCCAGGCTGGCGTTGTC-3 0 and 5 0 -TCTCTCCTCGA GCTCCTGGCCTGGGTGCTCACCTACAG-3 0 . The product was cloned into pcDNA6/V5-His cloning vector using EcoRI and XhoI restriction sites. Plasmid DNA was prepared using a QIAGEN Plasmid Kit or a QIAGEN EndoFree Plasmid Kit (QIAGEN, Hilden, Germany). For linearization of plasmid DNA, pmaxGFP was digested with XhoI, PvuII or SspI, whereas pcDNA6 constructs were digested with SphI or DraIII restriction enzymes, followed by ethanol precipitation. Complete digestion was confirmed by agarose gel electrophoresis. Capped and polyA-tailed mRNA were produced using an mMESSAGE mMACHINE T7 Ultra Kit (Ambion, Austin, TX, USA) and following the instructions of the manufacturer. One microgram of linearized pcDNA-GFP or pcDNA-CD79b served as the DNA template to produce GFP-specific or CD79b-specific mRNA. The quality of the mRNA preparations was examined with an Agilent Bioanalyzer using an RNA 6000 Nano Chip (Agilent, Waldbronn, Germany).
Nucleofection
A total 1-3 Â 10 6 primary B cells or B-CLL cells were transfected using an Amaxa Human B cell Nucleofector Kit and following the instructions of the manufacturer (Amaxa, Cologne, Germany). For both cell types, the nucleofector program U-15 was used. After nucleofection, cells were either added to pre-seeded HS-5 cells or cultured without stroma.
Cell viability
Apoptotic cell death was detected by flow cytometry using Annexin V and propidium iodide (PI) or 7-amino-actinomycin (7-AAD) staining. Cells were harvested and resuspended in Annexin V-binding buffer (10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)/NaOH, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 ) containing 10% Annexin V-FITC and 10% PI staining solution, or 10% Annexin V-PE and 10% 7-AAD staining solution (BD Biosciences, Heidelberg, Germany). After an incubation time of 15 min at 41C, stained cells were analyzed by flow cytometry, gating on lymphocytes. Double-negative cells were counted as viable cells. The results were confirmed on the basis of changes in forward light-scattering properties of dead cells that have decreased cell size.
Flow cytometry
GFP expression after nucleofection with various GFP constructs was measured by flow cytometry, and transfection efficiency was calculated as percentage of 100% viable cells by excluding 7-AAD-positive cells from the analysis. Percentages of B cells in PB MACS preparations were quantified using PE-conjugated monoclonal antibodies specific to CD19 (clone LT19; Miltenyi Biotec) and CD20 (clone LT20; Miltenyi Biotec). Purity of cell fractions after separating cocultured cells was quantified on the basis of different forward light-scattering properties of large HS-5 cells compared to small lymphocytes. All flow cytometry analyses were carried out using a FACSCalibur flow cytometer equipped with CellQuest software (BD Biosciences).
Western blotting
Transfected primary B-CLL cells were harvested and lysed in phosphate-buffered saline containing 0.5% NP-40, 1 mM MgCl 2 , 2 mg/ml aprotinin and 200 mg/ml 4-(2-aminoethyl)-benzenesulfonyl fluoride (ABSF), for 1 h on ice. Cell lysates were separated through 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes, which were incubated with anti-V5-horseradish peroxidase (HRP) antibodies or anti-b-actin-HRP antibodies (Invitrogen). CD79b-V5 fusion protein or b-actin was visualized using ECL Blotting Detection Reagents (Amersham Biosciences, Buckinghamshire, England). To evaluate the importance of soluble factors in providing survival signals for B-CLL cells in vitro, we performed experiments with conditioned medium of HS-5 stromal cell cultures. B-CLL cells were rescued from spontaneous apoptosis when cultured in conditioned medium, but survival was significantly lower compared to B-CLL cells cultured in the presence of HS-5 cells (Figure 1b) . In addition, survival rates of B-CLL cells in conditioned medium dropped considerably after 3 days of culture although fresh conditioned medium was added daily (data not shown). Therefore, soluble factors seem to play an important role in inducing survival of B-CLL cells, but either these factors have very short half-life or additional signals are required that are only transduced through direct cell-cell contact between B-CLL cells and stromal cells. Our results are in contrast to previously reported data, which show no reduction of spontaneous apoptosis of B-CLL cells in conditioned medium of stromal cells, that can maintain survival in cocultures. 13, 19 An explanation for this contradiction could be the differences in quality or quantity of soluble factors produced by the stromal cells used in these studies compared to the conditioned medium of HS-5 cells. A high sensitivity of the putative factors in the conditioned medium is corroborated by were cultured in 0.5 ml conditioned medium of HS-5 cells for 1-3 days, while adding fresh conditioned medium daily. Survival rates in these cultures were compared with B-CLL cells cultured either in the presence or in the absence of HS-5 stromal cells. Circles represent data points after 1 day, and triangles after 3 days of culture. B-CLL, B-cell chronic lymphocytic leukemia; PB, peripheral blood; PI, propidium iodide.
Results and discussion
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When using B-CLL/HS-5 cocultures, B-CLL cells had to be separated from the stroma for subsequent analysis. This was carried out by simply removing the suspended leukemic cells from the adherent HS-5 cell layer, which led to cell purities of approximately 90% in the case of HS-5 cells, and of 75% in B-CLL cells. Flow cytometry analyses were focused on the cell population of interest by gating on either HS-5 cells or B-CLL cells. Since these two cell types differ enormously in size, they can be easily distinguished in forward/side scatter plots. In addition, there are a number of cell surface markers that can be used to distinguish or sort the two cell fractions if higher purities are required.
Our data show that the stromal cell line HS-5 provides a longterm, survival-stimulating microenvironment for B-CLL cells and B cells. Therefore, these cocultures can be used as an in vitro model system mimicking the in vivo behavior of these cells. Table 1 is shown. 7-AAD, 7-amino-actinomycin; B-CLL, B-cell chronic lymphocytic leukemia; GFP, green fluorescent protein. (Figure 2a) . GFP expression could be detected as early as 3 h after nucleofection and was detectable for up to 5 days. In addition, we quantified cell viability after nucleofection by Annexin V and 7-amino-actinomycin D (7-AAD) staining. Survival rates of B cells or B-CLL cells 24 h after nucleofection with pmaxGFP showed some variability (between 20 and 60%), but were generally much lower compared to non-transfected cells.
Apoptosis of B cells and B-CLL cells in coculture after nucleofection
To elucidate the reason for the low viability of B cells and B-CLL cells after nucleofection, we compared survival rates of cells transfected with pmaxGFP, 'no DNA'-transfected cells, which were treated equally to the transfected samples, but no DNA was added to the sample, and 'no program' control cells, where 2 mg of pmaxGFP was added to the cells in the nucleofector solution, but the nucleofector program was not performed. Transfected cells were cultured over 3 days in the presence or absence of HS-5 stromal cells (Figure 2b ). Cell survival 3 h after nucleofection with or without DNA was similar to the 'no program' control. The nucleofection procedure itself is obviously not disruptive to B cells or B-CLL cells, but we repeatedly observed an increase in apoptotic cell death after 24 h as a result of the nucleofection procedure ('no DNA' control versus 'no program' control). The viability of cells could be extremely improved by transferring them immediately after nucleofection to HS-5 stromal cells or to their conditioned medium. Therefore, it is highly recommendable to combine nucleofection of primary B cells or B-CLL cells with an in vitro culture system that has long-term, survival-stimulating activity, like HS-5 cells.
Surprisingly, the viability of cells transfected with pmaxGFP was repeatedly lower compared to the 'no DNA' control, and the presence of HS-5 cells only partly improved cell survival ( Figure 2b and Table 1 ). This observed effect was independent of the plasmid preparation and transgene expression. Transfections with a second GFP-containing vector, pcDNA-GFP, resulted in lower transfection efficiencies, but in higher apoptosis rates compared to pmaxGFP. We further tested four plasmids containing protein-coding transgenes, two plasmids containing non-coding transgenes and one plasmid lacking a functional eukaryotic promoter sequence, as well as plain pcDNA6 vector. Nucleofection of all constructs resulted in high apoptotic rates. To exclude the possibility that impure DNA preparations are the reason for the apoptotic effect after transfection, we purified plasmid DNA using Qiagen's EndoFree Plasmid Kit. However, the rate of apoptosis was not reduced when endotoxin-free plasmid DNA preparations were used for transfections (Supplementary Information B). We further tested whether the amount of transfected DNA has an influence on the survival rates of the cells and could show that by decreasing the input of plasmid DNA from 4 to 0.125 mg per transfection, the viability of the cells increased, but as expected the expression of GFP decreased as well (Figure 2c ). In addition, we repeatedly observed a positive correlation between the size of the plasmid and the percentage of apoptosis, where large plasmids (e.g. pcDNA6 constructs) induced higher apoptotic rates compared to smaller plasmids (e.g. pmaxGFP) ( Table 1 and Supplementary Information C). Therefore, we conclude that the introduction of plasmid DNA into primary B cells and B-CLL cells induces apoptosis in these cells, even in the presence of a survivalstimulating microenvironment provided by HS-5 cells.
To learn more about the two types of apoptosis, that is, spontaneous apoptosis due to the lack of a survival-stimulating microenvironment and apoptosis induced by uptake of plasmid DNA after nucleofection of B-CLL cells, we quantified percentages of early apoptotic cells, which are Annexin V-positive, but 7-AAD-negative and Annexin V and 7-AAD double-positive late apoptotic cells, in transfected and nontransfected samples. Our results revealed that 24 h after nucleofection, introduction of plasmid DNA induced an increase in late apoptotic cells, whereas the lack of HS-5 cells led to an increase in early apoptotic cells but not in late apoptotic cells after pmaxGFP transfection (Figure 2d ). These data indicate that apoptosis induced by the introduction of plasmid DNA into B cells or B-CLL cells is more rapid and independent of spontaneous apoptosis triggered by the lack of survival-stimulating stromal cells.
Nucleofection of mRNA results in high transfection efficiency and cell viability
To investigate if the structure of the transfected nucleic acids has an effect on the apoptotic rate of B-CLL cells after nucleofection, we performed experiments using transfer of linearized plasmid DNA and in vitro transcribed mRNA into primary B cells and B-CLL cells. For linearization of plasmid DNA, we used different restriction enzymes (XhoI, PvuII and SspI for pmaxGFP, and SphI and DraIII for pcDNA6 constructs) to ensure that the observed effects are independent of the restriction site and of the resulting template length downstream of the coding sequence. The Table 1 Cell viability of B-CLL cells after nucleofection with various DNA and mRNA preparations Abbreviations: B-CLL, B-cell chronic lymphocytic leukemia; GFP, green fluorescent protein; ND, not determined.
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in vitro-transcribed mRNA molecules were capped and polyAtailed for stabilization reasons. Interestingly, cell survival after nucleofection with linearized plasmid DNA or mRNA was comparable to the control experiments, where no DNA or RNA was added to the nucleofection protocol ( Figure 3a and Table 1 ). In addition, we introduced siRNA molecules of selected specificities into primary B cells and B-CLL cells and did not observe any induction of apoptosis after uptake of these molecules (data not shown). Therefore, we conclude that only transfer of circular plasmid DNA, but not linear DNA or RNA molecules, induces apoptosis in transfected B cells or B-CLL cells. Apoptosis caused by the uptake and accumulation of DNA in the cytoplasm has been described for other cell types as well, including dendritic cells, macrophages and monocytic cell lines. [20] [21] [22] In addition, it has been shown that introduction of linearized plasmid DNA into monocytic cells resulted in reduced toxicity compared to supercoiled circular DNA, 21 which is in accordance with our results. A possible explanation for apoptotic cell death induced by the uptake of DNA might be issued from immune functions of these cells after certain retroviral infections. [23] [24] [25] Since B lymphocytes share with the cell types mentioned above the ability to present antigens, it is likely that they possess a similar response mechanism leading to apoptosis after cytoplasmic accumulation of foreign DNA. However, since the sensitivity of B lymphocytes for supercoiled circular DNA and linearized DNA differs considerably, the observed effect might be part of an uncharacterized viral defense system.
We next evaluated the expression levels of the transgene after nucleofection with linearized pmaxGFP and GFP-specific mRNA. As shown in Figure 3b , nucleofection with linearized pmaxGFP resulted in decreased transgene expression compared to circular pmaxGFP (33% GFP þ cells compared to 58% GFP þ cells). However, nucleofection of GFP mRNA into primary B cells and B-CLL cells resulted in even higher transfection efficiencies, with 80-90% GFP-positive cells. The intensity of the GFP signal per cell was weaker in transfections with mRNA compared to pmaxGFP transfections. This lower level of transgene expression is, however, in most cases more similar to the endogenous expression level of proteins and might therefore be more suitable to reveal functions of transgenes. We observed GFP expression in nucleofected cells from 3 h to 4 days after nucleofection with GFP-specific mRNA (data not shown). One reason for this rather long duration of transgene expression could be the relatively high stability of maxGFP in human cells. The overall duration of transgene expression depends certainly on the transgene itself and needs to be determined for each experiment individually.
We analyzed further transgene expression after nucleofection of B-CLL cells with pcDNA-CD79b plasmid DNA, linearized pcDNA-CD79b and CD79b-specific mRNA by western blotting. Figure 3c shows that transfection with mRNA results in potent transgene expression 6 h after transfection. A weaker expression of CD79b-V5 was detected after transfection with pcDNACD79b plasmid DNA, which is in line with the lower transfection efficiency observed with pmaxGFP compared to GFP-specific mRNA. A further explanation for this weaker transgene expression is the observation that transfections with pcDNA-GFP, with a size of 5.8 kb, repeatedly resulted in lower efficiencies compared to transfections with pmaxGFP with a size of 3.5 kb. Therefore, for an adequate estimation of transfection efficiency, it is important to use GFP-containing constructs within the same vector backbone as used for the gene of interest. We further observed even weaker expression levels of CD79b-V5 after transfections with linearized pcDNA-CD79b, which again confirms our results with circular and linearized pmaxGFP. Our data therefore show that it is highly recommendable to use mRNA molecules instead of plasmid DNA when transfecting primary B cells or B-CLL cells.
In summary, we present a new approach for maintenance of primary B cells and B-CLL cells in an in vitro model system 
